Experts warn of malnutrition risks on GLP-1s
University of Newcastle research finds critical gap in evidence on health hazards of rapid weight loss
Nutrition experts are warning that some Australians expected to use GLP-1 drugs such as Ozempic and Wegovy could be at risk of malnutrition and muscle loss, with new research from the University of Newcastle identifying a critical gap in evidence on the health hazards of rapid weight loss and GLP-1s.